Science:Life Sciences
Today's episode features the CEO of Tome Biosciences, Rahul Kakkar, alongside John Finn, CSO of Tome. They are joined by Jorge Conde, general partner at a16z Bio + Health.
Together, the three of them discuss the technology underlying Tome's work, known as PASTE, a genome editing technique. They also dive deep into how this technology could be applied to help patients, making cell therapy more accessible for more people.
Editorial note: We mistakenly identified Rahul Kakkar and John Finn as the co-founders of Tome Biosciences. In reality, Rahul serves as the CEO, and John is the CSO of Tome. The actual co-founders of Tome Biosciences are Jonathan Gootenberg and Omar Abudayyeh.
More Episodes
The Cost Disease in Healthcare
2020-12-14
2020-12-14
The Google Maps Moment in (Modeling) Biology
2020-12-07
2020-12-07
Journal Club: Bioengineering Birth
2020-12-03
2020-12-03
The Story of Schizophrenia
2020-11-30
2020-11-30
Food as Medicine
2020-11-24
2020-11-24
Health—at What Price?
2020-11-16
2020-11-16
Journal Club: Defeating Type 1 Diabetes
2020-11-12
2020-11-12
We, the Patients
2020-11-09
2020-11-09
The Thermodynamics of Life
2020-11-02
2020-11-02
The Biology of Pain
2020-10-19
2020-10-19
Biology by Design
2020-10-13
2020-10-13
Going Back to the Workplace in a Pandemic
2020-10-06
2020-10-06
Get this podcast on your
phone, FREE
